Skip to main content

Table 3 RNA-seq-based comparison of NPM1 transcript levels in AML and HV samples

From: NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome

Transcript AML-T0 AML-T1 HV AML-T0/HV TPM ratio
Median level (TPM) Contribution to the total NPM1 gene expression (%) Median level (TPM) Contribution to the total NPM1 gene expression (%) Median level (TPM) Contribution to the total NPM1 gene expression (%)
NPM1.1 950.37 63.68 473.63 63.02 445.485 55.73 2.13
NPM1.2 55.36 3.71 18.14 2.41 24.655 3.084 2.25
NPM1.3 62.88 4.21 45.8 6.09 52.505 6.569 1.20
NPM1.4 1.09 0.073 0.43 0.057 1.46 0.183 0.75
NPM1.5 0.76 0.051 0.37 0.049 0.655 0.082 1.16
NPM1.6 0.71 0.048 0.5 0.067 0.53 0.066 1.34
NPM1.7 4.53 0.304 3.07 0.408 13.785 1.725 0.33
NPM1.8 0.4 0.027 0 0 0.385 0.048 1.04
NPM1.9 412.59 27.65 206.85 27.52 256.25 32.06 1.61
NPM1.10 0 0 0 0 0 0
NPM1.11 3.7 0.248 2.77 0.369 3.61 0.452 1.02
total 1492.39 100 751.56 100 799.32 100